CCBIO has the pleasure of inviting you to the 13th CCBIO Annual Symposium May 13-14, and now, PREFINAL PROGRAM is available. To participate, please register within April 1. There will be a strong scientific program including a range of international speakers, among them Sir David Lane, Eva Hellström-Lindberg, Theodoros Foukakis, Anna Dimberg, Steinar Ø. Thoresen, Gema Moreno-Bueno and Jean […]
The Educational Working Group is planning an "AML Course Day" in conjunction with the Nordic AML Meeting in Bergen 2025. The AML Course Day covers topics such as the current diagnostics and therapeutics, the latest with regard to MRD as well as clinically inclined discussions on emergencies and infectious problems in AML. The AML Course […]
It's an open meeting for clinicians and preclinical researchers but meant for those that are actually interested to take part in future Nordic collaborative TP53 related myeloid research. The meeting will be held at Hotel Norge, Bergen, in connection with the NAMLG meeting, Room number will be announced at the hotel reception. The meeting will […]
Save the dates for the upcoming Nordic AML Meeting in Bergen, Norway, 2025.
Jazz Pharmaceuticals is pleased to invite hematologists from the Nordic AML Group to join a distinguished academic webinar featuring Prof. Dr. med. Lars Bullinger and Prof. Bjørn Tore Gjertsen, two leading experts in hematology and leukemia research. Find more info using this link. Register using this QR code
Agenda and meeting link will be sent via e-mail.
At Best of ASH 2025, hematologists in Lund, Sweden present their top picks from the annual meeting of the American Society of Hematology (ASH) cutting through the volume to focus on data that change how we treat patients. Expect concise, expert-led updates on key trials, late-breaking abstracts, and their real-world implications across hematology. Live on […]
The Nordic AML Group’s Educational Working Group invites you to a scientific webinar focusing on recent innovations in the treatment of AML and their implementation in Nordic clinical practice. The webinar will feature three expert speakers covering: - The evolving AML treatment landscape by professor Gail Roboz (New York) - Early Nordic experience with new […]
Agenda and meeting link will be sent via e-mail.
Join the MDR for patients with germline predisposition for hematological malignancies. This meeting is for clinicians within the Nordics via this Zoom-link. If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.
Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis, MD, PhD, Baltimore, USA, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda: Assess the current minimal residual disease testing modalities/methods Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities […]
Join the MDR for patients with germline predisposition for hematological malignancies. This meeting is for clinicians within the Nordics.via this Zoom-link. If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.